VA
VR Adviser’s Oric Pharmaceuticals ORIC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $67M | Buy |
6,596,885
+3,414,358
| +107% | +$34.7M | 5.02% | 6 |
|
2025
Q1 | $17.8M | Sell |
3,182,527
-1,212,000
| -28% | -$6.76M | 1.51% | 17 |
|
2024
Q4 | $35.5M | Hold |
4,394,527
| – | – | 2.43% | 15 |
|
2024
Q3 | $45M | Hold |
4,394,527
| – | – | 2.36% | 15 |
|
2024
Q2 | $31.1M | Hold |
4,394,527
| – | – | 1.98% | 17 |
|
2024
Q1 | $60.4M | Buy |
4,394,527
+1,966,142
| +81% | +$27M | 2.87% | 13 |
|
2023
Q4 | $22.3M | Buy |
2,428,385
+285,529
| +13% | +$2.63M | 1.53% | 22 |
|
2023
Q3 | $13M | Hold |
2,142,856
| – | – | 1.36% | 23 |
|
2023
Q2 | $16.6M | Buy |
+2,142,856
| New | +$16.6M | 2.66% | 16 |
|